Assuming multiple is required, the following results were found.

  • #ECTRIMS2019 - Transplanting MSCs Safe, Helps Stop Progressive MS - Multiple Sclerosis News Today

    Transplanting mesenchymal stem cells (MSCs) is safe and can delay disease progression in people with active, progressive multiple sclerosis (MS), according to results from a single-center clinical trial conducted in Israel. Six months after the...

    https://mschristian.org/index.php/articles/2-uncategorised/8603-ectrims2019-transplanting-mscs-safe-helps-stop-progressive-ms-multiple-sclerosis-news-today
  • Social cognition, mood and fatigue in multiple sclerosis

    A recent study by Kessler Foundation researchers linked the deficits in social cognition in multiple sclerosis with symptoms in other domains. The article, "Relationship between social cognition and fatigue, depressive symptoms, and anxiety in multiple...

    https://mschristian.org/index.php/articles/2-uncategorised/8405-social-cognition-mood-and-fatigue-in-multiple-sclerosis
  • Researchers find possible causes for lacking of effective therapy for multiple sclerosis

    Reviewed by James Ives, M.Psych. (Editor)Aug 20 2019 Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase. Many patients, however, develop progressive MS at a later stage,...

    https://mschristian.org/index.php/articles/2-uncategorised/8315-researchers-find-possible-causes-for-lacking-of-effective-therapy-for-multiple-sclerosis
  • Vaccinations do not raise risk of multiple sclerosis

    A large study has concluded that vaccinations are not a risk factor for multiple sclerosis. Instead, the findings reveal a consistent link between higher vaccination rates and a lower likelihood of developing the disabling condition. There is no...

    https://mschristian.org/index.php/articles/2-uncategorised/8172-vaccinations-do-not-raise-risk-of-multiple-sclerosis
  • How childhood viral infections may later drive multiple sclerosis

    Childhood viral infections that reach the brain may prime it for the development of autoimmune conditions, such as multiple sclerosis, later in life — this is what a recent study that scientists conducted in mice seems to suggest. Could viral...

    https://mschristian.org/index.php/articles/2-uncategorised/7889-how-childhood-viral-infections-may-later-drive-multiple-sclerosis
  • Multiple sclerosis treatments delay progression of the disease

    An international study finds multiple sclerosis treatments have long-term benefits, and that early treatment is important. The Royal Melbourne Hospital and University of Melbourne-led study is the first to provide evidence that the currently available...

    https://mschristian.org/index.php/articles/2-uncategorised/5282-multiple-sclerosis-treatments-delay-progression-of-the-disease
  • Multiple sclerosis drug slows brain shrinkage, study finds

    Results from a clinical trial of more than 250 participants with progressive multiple sclerosis (MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study also showed that the main side effects of ibudilast were...

    https://mschristian.org/index.php/articles/2-uncategorised/4405-multiple-sclerosis-drug-slows-brain-shrinkage-study-finds
  • Mindfulness training shows promise for people with MS

    New research suggests mindfulness training may help multiple sclerosis patients in two very different ways: regulating negative emotions and improving processing speed. People with MS who underwent the four-week mindfulness training not only improved...

    https://mschristian.org/index.php/component/easyblog/mindfulness-training-shows-promise-for-people-with-ms?Itemid=101
  • Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval of ZEPOSIA® (ozanimod) for the Treatment of Adult Patients with Relapsing Remitting Multiple Sclerosis with Active Disease | Small Molecules | News Channels - PipelineReview.com

    CHMP Opinion Recommending Approval of ZEPOSIA® (ozanimod) for the Treatment of Adult Patients with Relapsing Remitting Multiple Sclerosis with Active Disease Details Hits: 101 PRINCETON, NJ, USA I March 27, 2020 IBristol Myers Squibb (NYSE:BMY) today...

    https://mschristian.org/index.php/component/easyblog/bristol-myers-squibb-receives-positive-chmp-opinion-recommending-approval-of-zeposia-ozanimod-for-the-treatment-of-adult-patients-with-relapsing-remitting-multiple-sclerosis-with-active-disease-small-molecules-news-channels-pipelinereview-com?Itemid=341
  • Study underscores the influence of sensory processing in multiple sclerosis

    new findings about the role of sensory processing and disease characteristics in the functional status of individuals with multiple sclerosis. This is one of the first studies to look at the implications of sensory processing deficits in this...

    https://mschristian.org/index.php/component/easyblog/study-underscores-the-influence-of-sensory-processing-in-multiple-sclerosis?Itemid=341
  • Multiple Doses of Stem Cells Show Potential in Treating Severe Asthma - Yahoo Finance

    University of Rio de Janeiro and the National Institute of Science and Technology for Regenerative Medicine describe how multiple doses of a type of stem cell called mesenchymal stromal cells (MSCs) might offer a new way to treat people suffering from...

    https://mschristian.org/index.php/component/easyblog/multiple-doses-of-stem-cells-show-potential-in-treating-severe-asthma-yahoo-finance?Itemid=341
  • Experts evaluate options for treating cognitive deficits in multiple sclerosis

    research evaluated the status of available treatments as well as promising strategies for treating cognitive deficits in multiple sclerosis. The article, "Treatment and management of cognitive dysfunction in patients with multiple sclerosis", was...

    https://mschristian.org/index.php/articles/2-uncategorised/10900-experts-evaluate-options-for-treating-cognitive-deficits-in-multiple-sclerosis
  • Researchers uncover critical role of PKM2 protein in multiple inflammatory diseases

    Dublin has uncovered a critical role for a protein called 'PKM2' in the regulation of immune cell types at the heart of multiple inflammatory diseases. The work identifies PKM2 as a potential therapeutic target for treating a host of diseases mediated...

    https://mschristian.org/index.php/articles/2-uncategorised/9347-researchers-uncover-critical-role-of-pkm2-protein-in-multiple-inflammatory-diseases
  • The IDA Is Championing a Symbol for Invisible Disabilities - Multiple Sclerosis News Today

    me how good I look … even if I look and feel good. The week of Oct. 13 is Invisible Disabilities Week. As we all know, multiple sclerosis (MS) can be as invisible as Casper the Ghost. Invisible Disabilities Week isn’t limited to people with MS, of...

    https://mschristian.org/index.php/articles/2-uncategorised/8951-the-ida-is-championing-a-symbol-for-invisible-disabilities-multiple-sclerosis-news-today
  • How MS Affects Sleep Quality - Plus: Sleep Tips for People with Multiple Sclerosis

    feel like your energy levels disappear during the day? If so, you’re not alone. One of the hardest parts of living with Multiple Sclerosis (MS) is fatigue. MS fatigue is unique. Instead of the typical “tired” feeling that the general population might...

    https://mschristian.org/index.php/articles/2-uncategorised/8614-how-ms-affects-sleep-quality-plus-sleep-tips-for-people-with-multiple-sclerosis
  • Study investigates link between social cognition and fatigue, mood in multiple sclerosis

    B.Sc. (Editor)Aug 29 2019 A recent study by Kessler Foundation researchers linked the deficits in social cognition in multiple sclerosis with symptoms in other domains. The article, "Relationship between social cognition and fatigue, depressive...

    https://mschristian.org/index.php/articles/2-uncategorised/8406-study-investigates-link-between-social-cognition-and-fatigue-mood-in-multiple-sclerosis
  • Environmental factors may trigger onset of multiple sclerosis

    that certain environmental conditions may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis (MS). Myelin sheaths are the "insulating tape" surrounding axons; axons carry electrical impulses in neurons....

    https://mschristian.org/index.php/articles/2-uncategorised/4536-environmental-factors-may-trigger-onset-of-multiple-sclerosis
  • New compound offers superior therapeutic approach to treat MS

    Multiple sclerosis is an autoimmune disease that affects more than 2.3 million people worldwide. This debilitating condition periodically shutters communication between the brain and other parts of the body, resulting in symptoms that range from...

    https://mschristian.org/index.php/component/easyblog/new-compound-offers-superior-therapeutic-approach-to-treat-ms?Itemid=341
  • A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple Sclerosis

    Abstract Background: When population-based databases are unavailable, nationwide assessments of the disease burden of multiple sclerosis (MS) resort to clinical, administrative or convenience-sampled data sources, which may produce results of limited...

    https://mschristian.org/index.php/articles/2-uncategorised/9970-a-framework-for-estimating-the-burden-of-chronic-diseases-design-and-application-in-the-context-of-multiple-sclerosis
  • Disability in multiple sclerosis A reference for patients and clinicians

    Abstract Objective: To create a reference table of disability outcomes in multiple sclerosis (MS) that would enable patients to rank their disability relative to others' with similar disease duration and to develop a cost-effective research tool for...

    https://mschristian.org/index.php/articles/2-uncategorised/9969-disability-in-multiple-sclerosis-a-reference-for-patients-and-clinicians

Results 101 - 120 of 874